Article

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management-05-07-2014
Volume10
Issue 5

Janssen Pharmaceutical Collaborates with Stiching International Dispensary Association

Author(s):

Janssen Pharmaceutical collaborates with Stop TB Partnership's Global Drug Facility to increase access to anti-TB compound.

Johnson & Johnson reported its affiliate Janssen Pharmaceutical NV has entered into a collaboration with the Stiching International Dispensary Association (IDA), a procurement agent for the Stop TB Partnership’s Global Drug Facility (GDF), to facilitate access to the company’s anti-tuberculosis medicine. This public-private partnership was established by the newly formed Janssen Global Public Health, to help improve overall public health.

More than 130 low- and middle-income countries outside of the US will now be able to obtain this new anti-tuberculosis medicine through the procurement processes of GDF and its agent, the IDA.

Source: Johnson & Johnson

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
Tariffs & Trade Policy: Results of a Bio/Pharma Peer Survey
Understanding the Operational Impacts of the 15% US-EU Pharma Tariff Cap